Position in BCRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$194,417
+$76,617 QoQ
Shares Held
20,422
+31.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026nVerses Capital, LLC holds $2,151,615 across 8 Drug Manufacturers - Specialty & Generic names. BCRX ranks #6 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
11,237 | $424,084 | |
| 2 | ZTS |
Zoetis Inc.
|
3,500 | $413,735 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
17,685 | $346,449 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
11,213 | $341,772 | |
| 5 | PRGO |
PERRIGO Co plc
|
26,033 | $279,594 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
20,422 | $194,417 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
32,554 | $114,264 | |
| 8 | LFCR |
Lifecore Biomedical, Inc. \De\
|
10,027 | $37,300 |
All Filings in BCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,417 | 20,422 | Shares | Sole | 2026-05-13 | |
| 2024-09-30 | $117,800 | 15,500 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $63,036 | 10,200 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||